1. Home
  2. VNT vs CYTK Comparison

VNT vs CYTK Comparison

Compare VNT & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VNT
  • CYTK
  • Stock Information
  • Founded
  • VNT 2019
  • CYTK 1997
  • Country
  • VNT United States
  • CYTK United States
  • Employees
  • VNT N/A
  • CYTK N/A
  • Industry
  • VNT Industrial Machinery/Components
  • CYTK Biotechnology: Pharmaceutical Preparations
  • Sector
  • VNT Industrials
  • CYTK Health Care
  • Exchange
  • VNT Nasdaq
  • CYTK Nasdaq
  • Market Cap
  • VNT 5.4B
  • CYTK 4.4B
  • IPO Year
  • VNT N/A
  • CYTK 2004
  • Fundamental
  • Price
  • VNT $40.99
  • CYTK $36.11
  • Analyst Decision
  • VNT Buy
  • CYTK Buy
  • Analyst Count
  • VNT 7
  • CYTK 14
  • Target Price
  • VNT $46.40
  • CYTK $70.92
  • AVG Volume (30 Days)
  • VNT 1.1M
  • CYTK 1.3M
  • Earning Date
  • VNT 07-31-2025
  • CYTK 08-07-2025
  • Dividend Yield
  • VNT 0.25%
  • CYTK N/A
  • EPS Growth
  • VNT 1.28
  • CYTK N/A
  • EPS
  • VNT 2.63
  • CYTK N/A
  • Revenue
  • VNT $3,041,400,000.00
  • CYTK $19,218,000.00
  • Revenue This Year
  • VNT $2.32
  • CYTK $27.08
  • Revenue Next Year
  • VNT $4.92
  • CYTK $652.09
  • P/E Ratio
  • VNT $15.34
  • CYTK N/A
  • Revenue Growth
  • VNT 1.16
  • CYTK 412.21
  • 52 Week Low
  • VNT $27.22
  • CYTK $29.31
  • 52 Week High
  • VNT $42.00
  • CYTK $59.39
  • Technical
  • Relative Strength Index (RSI)
  • VNT 68.46
  • CYTK 48.72
  • Support Level
  • VNT $39.36
  • CYTK $35.50
  • Resistance Level
  • VNT $42.00
  • CYTK $38.59
  • Average True Range (ATR)
  • VNT 0.92
  • CYTK 1.40
  • MACD
  • VNT 0.18
  • CYTK -0.27
  • Stochastic Oscillator
  • VNT 92.92
  • CYTK 12.47

About VNT Vontier Corporation

Vontier, spun off from Fortive in 2020, is an industrial technology company with a portfolio of transportation and mobility solutions. The company offers a wide array of products and services, including fueling equipment, sensors, point-of-sale and payment systems, telematics, and equipment used by vehicle mechanics and technicians. Vontier generated approximately $3 billion in sales in 2024.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: